A system to improve screening and treatment for opioid use disorder in Chicago.
Chicago Data-driven OUD Screening, Engagement, Treatment and Planning (C-DOSETaP) System
This study is looking for better ways to help people in Chicago who are struggling with opioid use disorder by using smart technology to find those at risk and improve their care and support.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10745471 on NIH RePORTER |
What this research studies
This research focuses on enhancing the prevention, treatment, and recovery support for individuals with opioid use disorder (OUD) in Chicago. By utilizing advanced data-driven methods, including machine learning and analysis of electronic health records, the project aims to identify individuals at risk for OUD and improve clinical care. The approach integrates various healthcare resources and community data to optimize treatment planning and resource allocation, ultimately aiming to reduce the impact of OUD in the community.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for or currently experiencing opioid use disorder, particularly those residing in the westside of Chicago.
Not a fit: Patients who do not have any risk factors for opioid use disorder or who are not located in the targeted geographic area may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective identification and treatment of opioid use disorder, potentially saving lives and improving patient outcomes.
How similar studies have performed: Similar data-driven approaches have shown promise in improving treatment outcomes for opioid use disorder, indicating potential for success in this innovative project.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Karnik, Niranjan Subhash — University of Illinois at Chicago
- Study coordinator: Karnik, Niranjan Subhash
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.